Ealixir, Inc.
EAXR · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -737.95 | -0.26 | 0.11 |
| FCF Yield | 0.00% | -0.06% | 0.31% | 0.22% |
| EV / EBITDA | 0.00 | 1,237.74 | 1,025.77 | -127.82 |
| Quality | ||||
| ROIC | 0.00% | 0.08% | 42.72% | 427.87% |
| Gross Margin | 0.00% | 91.84% | 93.72% | 35.44% |
| Cash Conversion Ratio | -1.11 | -253.84 | 0.58 | -0.31 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.96% | -17.78% | -24.42% | -30.55% |
| Free Cash Flow Growth | -1.29% | -121.96% | 21.74% | 666.78% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.72 | 0.00 | -0.28 |
| Interest Coverage | 0.00 | 6.90 | 11.62 | -178.85 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -308.33 | -1,044.54 | -216.66 |